Effect of delayed supplementation of fetal calf serum to culture medium on bovine embryo development in vitro and following transfer.
Supplementation of synthetic oviduct fluid (SOF) medium plus amino acids and bovine serum albumin (BSA) with either fetal calf serum (FCS) or charcoal-treated FCS (CT-FCS) from Day 5 of development was investigated to determine if either in vitro or post-transfer development was altered. Development to the compact morula stage or beyond was similar for all 3 treatments. However, blastocyst development at Day 7 was accelerated when serum was added to the medium (21.6, 40.1 and 39.4% blastocysts from cleaved embryos for BSA, FCS and CT-FCS, respectively; P < 0.01), but cell number of the resulting embryos was unaffected. Furthermore, addition of CT-FCS decreased the between replicate variation in embryo development and produced more Grade 1 and 2 quality embryos (25.8%) than BSA supplementation (18.1%; P < 0.05). The transfer of Grade 1 and 2 embryos at Day 7 following culture resulted in similar pregnancy and embryo survival rates for the 3 treatments, with a tendency for lower embryo survival of embryos cultured in FCS (embryo survival at Day 50 = 37.7% vs 53.3% and 57.6% for FCS, BSA and CT-FCS, respectively; P = 0.1). Significant fetal loss from Day 50 to term occurred within all 3 treatments. There were no birth weight differences for calves amongst the 3 culture treatments; however, one of the sires produced calves that were significantly heavier than expected, suggesting a possible sire-by-embryo interaction. These results demonstrate that addition of FCS may promote blastocyst development; however, there was also a tendency for lower embryo survival. Thus charcoal treatment of FCS is recommended, because it decreases variability in embryo development between runs and results in embryo survival rates to term similar to that BSA-supplemented media.
Thompson
J G
JG
AgResearch, Ruakura Research Centre, Hamilton, New Zealand.
Allen
N W
NW
McGowan
L T
LT
Bell
A C
AC
Lambert
M G
MG
Tervit
H R
HR
D000818:Animals; D001724:Birth Weight; D002417:Cattle / Q000097:blood / Q000196:embryology* / Q000502:physiology; D002606:Charcoal / Q000737:chemistry; D003470:Culture Media / Q000737:chemistry; D003911:Dextrans / Q000737:chemistry; D004624:Embryo Transfer / Q000662:veterinary*; D005314:Embryonic and Fetal Development; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary*; D005312:Fetal Blood / Q000502:physiology*; D008297:Male; D010865:Pilot Projects; D010952:Plasma Substitutes / Q000737:chemistry; D011247:Pregnancy; D011897:Random Allocation
D003470:Culture Media; D003911:Dextrans; D010952:Plasma Substitutes; D002606:Charcoal